Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Type 2 Diabetes Mellitus.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00287066
What this trial is testing

A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition

Who this might be right for
Diabetes Mellitus
Pfizer 22
Post-approval studies (Phase 4)Study completedNCT00184626
What this trial is testing

Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 97
Early research (Phase 1)Study completedNCT05452525
What this trial is testing

Pharmacokinetics and Safety/Tolerability Profile of CKD-379

Who this might be right for
Type II Diabetes Mellitus
Chong Kun Dang Pharmaceutical 24
Testing effectiveness (Phase 2)Study completedNCT03058289
What this trial is testing

A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6

Who this might be right for
Breast CancerHead and Neck CancerSquamous Cell Carcinoma+8 more
Intensity Therapeutics, Inc. 111
Large-scale testing (Phase 3)Study completedNCT02033889
What this trial is testing

Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007).

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 621
Testing effectiveness (Phase 2)Study completedNCT00611884
What this trial is testing

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 245
Not applicableStudy completedNCT01786421
What this trial is testing

Diurnal Triglyceridemia in Relation to Alcohol Intake

Who this might be right for
Healthy SubjectsHyperlipidemiasType 2 Diabetes Mellitus+1 more
Sint Franciscus Gasthuis 273
Large-scale testing (Phase 3)Ended earlyNCT01453049
What this trial is testing

An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 86
Early research (Phase 1)Study completedNCT04354090
What this trial is testing

Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JY09

Who this might be right for
Diabetes Mellitus, Type 2
Beijing Dongfang Biotech Co., Ltd. 41
Early research (Phase 1)Study completedNCT07039890
What this trial is testing

To Compare and Evaluate the Oral Bioavailability of Empagliflozin + Linagliptin 10 mg/5 mg Filmcoated Tablets With That of Glyxambi 10 mg/ 5 mg Film-coated Tablets in Healthy, Adult, Human Subjects Under Fasting Conditions.

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Humanis Saglık Anonim Sirketi 40
Testing effectiveness (Phase 2)Study completedNCT02737891
What this trial is testing

Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Saniona 60
Early research (Phase 1)UnknownNCT02817243
What this trial is testing

The DDI Study of SP2086 and Simvastatin

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 24
Early research (Phase 1)Study completedNCT01458210
What this trial is testing

The Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Participants

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 22
Testing effectiveness (Phase 2)Ended earlyNCT01752985
What this trial is testing

Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Bristol-Myers Squibb 319
Testing effectiveness (Phase 2)Study completedNCT01725126
What this trial is testing

To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes

Who this might be right for
Obesity
GlaxoSmithKline 53
Not applicableStudy completedNCT02228252
What this trial is testing

The Effect of Protein Quality and Time-factor by Consumption of a Pre-meal on Postprandial Lipemia in Subjects With the Metabolic Syndrome.

Who this might be right for
Metabolic Syndrome
Aarhus University Hospital 16
Testing effectiveness (Phase 2)Study completedNCT00612040
What this trial is testing

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 178
Testing effectiveness (Phase 2)Study completedNCT00473525
What this trial is testing

12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 303
Not applicableStudy completedNCT00706017
What this trial is testing

Observational Study to Evaluate the Safety of Levemir® in Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 2,282
Early research (Phase 1)Study completedNCT01664624
What this trial is testing

Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes

Who this might be right for
Type 2 Diabetes
AstraZeneca 40
Next Page